Institute of Progressive Medicine
USA View Profile
Virology; Stealth adapted viruses; Herpes viruses; Cytomegalovirus; HIV; Biophysics; Cellular energy; Cellular immunity; Homeopathy; Complimentary and Alternative Medicine; Autism; Mental illnesses; Psychiatry; Neurology; Neuropathology; Water
Dr. W John Martin is Medical Director of the Institute of Progressive Medicine, within MI Hope Inc., a non-profit United States public charity specializing in the study of viruses causing mental illnesses. He received his medical degree from the University of Sydney in 1965 and the PhD degree from the University of Melbourne in 1970. He is Board Certified in both Anatomic and Clinical Pathology with subspecialty qualifications in Immunopathology and in Medical Microbiology. Using molecular assays and specialized virus culture techniques, he pioneered research leading to the detection of stealth adapted viruses and the alternative cellular energy (ACE) pathway. He explains the ACE pathway in terms of a natural energy force termed KELEA (kinetic energy limiting electrostatic attraction). He has further shown that water and other materials can capture and beneficially transmit KELEA to humans, animals and plants. He works in South Pasadena, California, USA.
Drexel University College of Medicine
USA View Profile
Molecular Mechanisms; Treatment; Prevention of Immunologic Abnormalities; Cancer; Progressive Neurologic Disorders Caused by Members of the Retrovirus and Herpes Virus Families
Brian Wigdahl, Ph.D., is professor and chair of Microbiology and Immunology, director of the Institute for Molecular Medicine and Infectious Disease, and director of the institutes Center for Molecular Virology and Translational Neuroscience at the Drexel University College of Medicine. An internationally recognized molecular virologist, he focuses his immediate research on the molecular mechanisms, treatment, and prevention of immunologic abnormalities, cancer, and progressive neurologic disorders caused by members of the retrovirus and herpesvirus families. He has a total of more than 180 published or in press peer-reviewed publications. He has been funded by the National Institutes of Health and other agencies, foundations, commercial sources for over 35 years, with awards totaling more than $40 million. A senior associate editor of the Journal of NeuroVirology, he also served for six years as president of the International Society for NeuroVirology, and currently serves as treasurer of the Society. During his time at Penn State, he was awarded the Samuel Hinkle Society Outstanding Young Investigator award and more recently at Drexel University College of Medicine, the Julian Marsh, MD, Faculty Scholar Award for excellence in scientific research, outstanding teaching skills, and consistent high quality leadership. He is the 2013 recipient of the International Society for NeuroVirology Pioneer in Neurovirology Award presented in recognition of outstanding individual achievement in the field of neurovirology.
InVentive Health Clinical
USA View Profile
Drug discovery; Drug development and Drug safety
Hongrong Cai born in the countryside of Yancheng in the Northern Jiangsu Province of China, he is a U.S. certified MD who completed postdoctoral training at the University of Maryland Medical School, specialized in oncology/internal medicine. His research project related to transgenic mouse as a model for breast cancer oncogenesis He also completed his Masters in Immunology at the Peking Union Medical College in 1990 and Masters in Biochemistry at the University of Maryland, Baltimore in 1998. He has a long time experience working in drug development, especially the development of vaccines and therapeutic monoclonal antibodies in aclinical, academic, and pharmaceutical environment. In recent years he focuses on pharmacovigilance practice in clinical trial and post marketing setting as a medical director in pharmacovigilance and drug safety with EMD Serono and InVetive Health Clinical. He is the first who indicated signal detection activity not only helps to maintain the safety profile of the drug, but also can be used to direct the modification of the drug, especially therapeutic antibody (molecular pharmocovigilance).
Florida International University Miami
USA View Profile
Biology; Microbiology; Parasitology; Immunology; Molecular Biology; Epigenetics; HIV; Neurocognitive Disorder, Synaptic Plasticity, Cell Biology.
Dr. Atluri has obtained his Ph.D. from Postgraduate Institute of Medical Education and Research, Chandigarh, India in 2009. He moved to Florida International University (FIU), Miami, FL, USA to pursue his post-doctoral research and subsequently appointed as assistant professor in the Department of Immunology at FIU. His current research is focused on neuropathogenic mechanisms of HIV infection and drugs of abuse; and epigenetic regulation of synaptic plasticity genes expression and spine density in HIV exposed neuronal cells. For the first time, Dr. Atluri’s group has reported the dysregulation of synaptic plasticity genes and spine density in HIV exposed neuronal cells and reported the usefulness of vorinostat as a therapeutic agent to inhibit the negative regulatory effects on synaptic plasticity in HIV infection. In his research career, he has published many research papers and abstracts in peer-reviewed scientific journals. He has been serving as an Editorial Board member of Frontiers in Microbiology (Section Virology), AIDS and Behavior, International Journal of Nanomedicine, Neuropsychiatric disease and treatment, HIV/AIDS-Research and Palliative Care etc.; and reviewer of many peer-reviewed scientific journals. He is recipient of gold medals for being outstanding undergraduate and college topper for the year 2000 from V.K.R. College, Nagarjuna University, India. He has also received many travel awards to attend national and international scientific meetings.
Global Head Clinical Immunology & Biomarkers
USA View Profile
Immunology; Personalized Medicine
Claudio Carini has been involved in biomedical research for over 20 years, and his experience includes all stages of biomedical research from bench experimentation to clinical research. He is board certified in Internal Medicine, Pathology, Respiratory Medicine, and Clinical Immunology. He obtained his MD in Italy. Later, he earned the PhD in Immunology from the University College London (UCL), University of London and subsequently an FRCPath in Immunology from the Royal College of Pathologists, London and Specialists Diplomas for Clinical Immunology and Respiratory Medicine from the University of Rome. Currently, he is serving at Pfizer as “Global Head of Clinical Immunology and Biomarkers” and holds as well a Hon. Faculty at King’s College, School of Medicine, Univ. of London.
Temple University, USA View Profile
Murine Virology; Antiviral Chemotherapy; Effects of inhibitors on viraI replication; Studies on the role of herpesviruses in cancer; Tumor immunology; Pathology of AIDS
UC Davis Medical Center, USA View Profile
Molecular Virology, Microbiology, Immunology
Maged Gomaa Hemida
King Faisal University
Saudi Arabia View Profile
Virus host interaction; Molecular biology of Coronaviruses; Emerging and Re-emerging viral disease
Maged Gomaa Hemida is an assistant professor of Molecular Virology. He received his DVM and master degrees from the virology department, College of Veterinary Medicine, Kafrelsheikh, Egypt. He also graduated from the Ontario Veterinary College (OVC), University of Guelph, Canada early 2009. During the tenure of his Ph.D., He studied the Molecular and Biological characterization of Turkey Coronavirus,an isolate from Ontario. He already established the genome structure and organization for this virus for first time. He developed several novel diagnostic assays and studied the molecular pathogenesis of this particular virus. Immediately after his graduation, he pursued his postdoctoral training at the Heart and Lung Institute, James Hogg iCapture Centre, at the faculty of Medicine, University of British Columbia, Canada. He studies the potential roles of small RNA moleculesMicroRNAS (miRNA) in in the molecular pathogenesis of CVB3 infection. He identified several miRNA candidates that affect the pathogenesis of CVB3 replication both in vitro in cell culture and in vivo in mouse model. Currently, he is acting as an assistant professor of Molecular virology at the Department of Microbiology and Parasitology, College of Veterinary Medicine and Animal Resources, King Faisal University, Saudi Arabia. His current research area of interest is the One Health concept with special emphasis on the virus host interaction. He is currently focusing on the molecular evolution and pathogenesis of MERSCoV. He already published many international per reviewed publications, review articles, book chapters and books. He is also acting as a reviewer for many international journals and grant agencies.
University of Calgary, Canada View Profile
Cancer Biology, Immunology, Hematology, Bone Marrow Transplantion
Olga V. Morozova
Novosibirsk State University, Russia View Profile
Virology, Molecular Virology, Biochemistry
China View Profile
Infectious Diseases; Particularly in hepatitis and HIV diagnostics and therapeutic monitoring
Peng Yin, M.D., PhD, FACB is Currently the Director, Abbott R/D Center, China, Diagnostics Research, Abbott. He Received M.D. from Tianjin Medical School, China and worked as a General Surgeon for 5 years, then received PhD in Molecular Virology from University of Manitoba, Canada and postdoctoral training at Harvard University, Medical School. He is a Fellow of the National Academy of Clinical Biochemistry (NACB) (U.S.). Prior joining Abbott, he worked as a Senior Scientist in biotech companies in USA. He has patent, book chapter and publications in Nature publication, Cell and Journal of Virology. He Invited to give speeches in Scientific Symposia around the world, such as Australia NRL Annual Meeting, China National Liver Diseases Laboratory Diagnosis and Clinics Conference. He is a Honorary Professor, Tianjin Medical University Cardiovascular Institute, TEDA International Cardiovascular Hospital. He is also IFCC Congresses and Conference Executive Committee Member and AACC Chair, Industry Division and Editorial Board of Journal of Human Virology & Retro Virology
Gamil sayed Gamil Zeedan
National Research Center
Egypt View Profile
His research focuses on the Molecular typing and epidemiological studies of viruses of animal origin with special interest of zoonotic ones.
Gamil GS Zeedan obtained Ph.D. Virology, Cairo University Egypt, MVSCs Virology, Cairo University. BVSCs, Cairo University. Currently 2014 up to date Assistant professor at National Research Center (NRC)- Cairo-Egypt. 2010- 2013 Assistant Professor in the Department of Microbiology and Virology at Collage of Medicine and Applied Medical sciences, Saudi Arabia. He was teaching the following curriculum, Medical Microbiology and Virology, Diagnostic Microbiology, Clinical Rotation of Microbiology and Clinical Rotation Immunology & Virology. Title of supervised projects: Development of a Therapeutic Vaccine against Hepatitis B Virus - Incidence of hepatitis A, B, C, D and E in Saudi Arabia. The laboratory diagnosis of hepatitis B virus- Human immunodeficiency virus (HIV) infection testing technologies & strategies -Hepatitis C virus virological studies and diagnosis of liver diseases. He published many articles in reputed journals supervising postgraduate students and serving as an editorial board member of reputed journals.
Egypt View Profile
Virus-host interaction; Viral Zoonosis
Refat Sadeq, from Egypt who has been on microbiology over 37 years. He has started and graduated in Zagazig Faculty of Medicine for M.Sc. and Ph.D. Then started to research articles reaching more than 80 articles, many of which have been published in international scientific journals, and he has reviewed over 100 edits on different journal sites. He is a Featured Author, for books in Medical Microbiology and Immunology for both medical students and nurses. Work from 2008-2011 as Head of Microbiology Department, Faculty of Medicine- Zagazig University. Also work as member of Egyptian scientific committee for graduation of Professor and assistant Professor in Microbiology. Since Oct 2014 he pointed as a Head of Microbiology and Immunology department, Faculty of Medicine, Portsaid University. Also he works as Manager of Portsaid University Hospitals. He is very goal-oriented, he assisted in building many units in his department but the favorite one was that of Virology and Molecular biology. He loves how to help junior doctors in his department to solve their scientific problems. His advice to new contributors is to take your time to get to know all the tools and to invest your energy and be sure that success will happened.
India View Profile
Molecular Factors; Mechanisms and Therapies of Hematological Disorders in HIV Infection and in Mother to Child Transmission of HIV Infection; Pre-clinical Translational Humanized In Vivo Model Systems - NOD/SCID-hu Mice (Human Fetal Thymus/Liver Conjoint Organ Growth +/- Autologous CD34 Cell Engrafted); Human Hematopoietic Stem Cell (hHSC) Differentiation in HIV Infection and in generation of Cancer Stem Cells using these Chimeric Humanized Mice In Vivo; Gene and Drug Therapy for Rescue from Hem
Prasad Koka obtained his PhD in 1977 with a Biochemistry and Physical Chemistry as major and minor areas respectively from Texas Tech University, beginning with his graduate education in the year 1969 at University of Miami and completing my Masters degree from University of Missouri Columbia, he have gradually over the years turned into a biomedical scientist, researcher and professor. Equipped with a dissertation in biophysics/biochemistry, he has performed hands-on research in photobiology, Bacteriophage, Retrovirology, Immunogenetics, transplantation, neuro-AIDS-dementia, and HIVusing humanized SCID mice. His research then turned into stem cells with emphasis on cancer stem cells generation in vitro and in vivo and the potential role of hematopoietic and mesenchymal stem cells in the relapse and susceptibility to therapies of cancer. For almost 25 years out of his 40 years of scientific work, the research focus to date has been on HIV/AIDS including cytopenias/hematopoietic in HIV infection, mother to child transmission of HIV infection through the placental membrane, and currently on the identification and characterization of host cellular factors that inhibit hematopoiesis in HIV infection (even in the absence of anti-retroviral drugs that also contribute to cytopenias). His Retrovirology and human virology expertise has been acquired or developed in Massachusetts Institute of Technology, Harvard Medical School, University of California Los Angeles, Torrey Pines Institute for Molecular Studies (San Diego), and presently at Haffkine Institute in Mumbai, India.
University of Nyala
Sudan View Profile
Virus host interaction; Viral Zoonosis
Mohamed Haroun, a graduate of University of Khartoum, Sudan, is Professor of Veterinary Virology and Immunology and Staff Member of the Faculty of Veterinary Science, University of Nyala, Sudan. Beside, he is currently entitled Virology Expert at Virology Unit, Veterinary Laboratory, Department of Animal Resources, Ministry of Environment, State of Qatar, a diagnostic and a research unit aiming at achieving the international standards for diagnosing viral diseases following ISO Norms. His successive association with paramyxoviruses during his MVSc and PhD graduate programs has given him a broad base and a respectable insight on viruses and their related diseases. His investigations on Analysis of cellular and humoral immunity to rinderpest viruses (RPV) in both temperate and zebu cattle during the PhD study program has furnished him with a solid experience in virology, immunology and molecular techniques, a status that paved him to traverse the professional boundaries, building handy research ties with some renounced research oriented institutions such as Pirbright Institute for Animal Health in UK. The 25 years of the continuous association with teaching, research, administration and consultancy in universities and affiliated institutions, enabled him to establish strong interdisciplinary research ties with both funding and research conducting institutions such as Qatar Foundation and Cornell University, respectively. This situation has experienced researches the current of which are on viral zoonosis with special reference to RVFV and WNDV along with foodborne pathogens. In addition to his concern with molecular characterization and phylogenetic analysis of Newcastle disease viruses in Qatari avid species, he is currently supervising graduate students on FMDV and equine viral diseases.
National Institute of Genetic Engineering and Biotechnology
Iran View Profile
Studying Regulation of Bacterial Operons and developing novel expression systems. Developing various bacterial surface displays (including B.subtilis and E.coli) which will finally be applied in vaccine development and bioadsrobent Expression of industrial enzymes including chymosin, chitinase and so on and use of Genetics Engineering methods to Improve Enzyme activity Study on Extremephiles and extremozymes (enzymes which are active at extreme conditions like high temperature, high salt and others. These have many industrial applications. One example is Taq polymerase
3/2002-now Associate Professor, NIGEB, Iran 9/2008-12/2013 Head of research management office, NIGEB 1/2006-4/2006 A Short-term fellowship in Shinshu University, Ueda, Japan 3/2005- 6/2005 A Short-term fellowship in Department of Bacteriology, ICGEB, Italy. 1/2002-4/2002 A Short-term fellowship in Institute of Medical science, Tokyo University, Japan. 1998-2002 Post-doctoral fellowship in research institute of Hospital for Sick Children (Affiliated to University of Toronto). Education: 1994-1998 Received Ph.D. in molecular virology and cell biology from Department of Biological Sciences of Warwick University in U.K. 1992-1994 Work in a diagnostic molecular biology laboratory in a Amir-Kabir Hospital. Iran 1989-1992 Received M.Sc in medical microbiology, Tehran University, Iran 1984-1988 Received B.Sc. in Microbiology, Tehran University, Iran
Abdulghani Mohamad Alsamarai
Tikrit University College of Medicine
Iraq View Profile
Since 1977 his research focused on several issues including fungal, viral, bacterial, allergic and dermatologic diseases. Recently, he focuses on the role of oxidants / antioxidants, non invasive biomarkers of allergic diseases.
Professor Abdulghani Mohamad Alsamarai completed his undergraduate studies at College of Medicine, Basrah University in 1977 and received his MGUM degree in Genitourinary Medicine in 1988 and Ph D in Clinical Virology  from Sheffield University, UK. He assumed a faculty position in College of Medicine, Basrah University in 1986. Now he completed 31 years working as consultant in Allergy, Dermatology, Infectious Diseases and Medical Education in Basrah and Tikrit Universities. At Universities [Basrah, Tikrit, Lahaye international] he has served as a Teaching Assistant, Lecturer, Assistant Professor and full Professor in 1994. He appointed as Dean of Tikrit University College of Medicine from 2000 to 2003, Chairman of Tikrit University Promotion Committee and a Dean of College of Applied Medical Sciences, Lahaye International University. In addition, he is acting as Director of Joint Diploma for Health Profession Education Programme and WHO senior consultant. He was awarded grade A senior scientist because of his contribution in National Drug Formulation Programme and Community Health Promotion Research Programme. One of his responsibilities was to set up a postgraduate studies in Basrah University Medical College, acting as chairman of Examination Committee and Department of Microbiology, Basrah Medical College. In 1991 he join Tikrit University College of Medicine [TUCOM] as assistant professor and work to set up the Departments of Research in the university, and Medical Education Department, Curricula for Dermatology, Medicine, Surgery and Gynecology in TUCOM. Furthermore, once he joined TUCOM he is acting as chairman for Research Committee, Promotion Committee, and 6th year Learning Committee. He teaches several courses in undergraduate and postgraduate studies in Basrah Medical College and TUCOM. These courses include: Fungal diseases, Clinical Virology, Sexually Transmitted Diseases, Medical Education, Health Profession Education, Dermatology, Infectious Diseases, Allergic Diseases and Research Methods. He acts as Director of M Sc and Ph D in Medical Microbiology, High Diploma in Allergy and Immunological Diseases, and Joint Diploma in Health Profession Education with Suez Canal University, Faculty of Medicine. He has received a good contribution from National and International agencies to support his research on drug formulation, searching for new drugs, bioavailability of drugs, Plant products research, National Programme for Prevention and Control of Disease, and Community Health Promotion Research.
Mahmoud YM Taha
Iraq View Profile
Human herpes viruses specially HSV-1; EBV; CMV and their relations to periodontitis; Periapical lesions and aphthous stomatitis as well as the role of interleukins in Different t oral Diseases
Mahmoud YM Taha (BVMS, MSc, PhD, Ml.Biol, DcPath is a graduate of Baghdad Vet. Medical college 1979. Then he obtained MSc degree in Virology. After that he trained on Diagnostic virology in Rasheed Military Hospital. In 1984 he became a member of the scientific staff of Dental College, Mosul University. In 1990 he obtained his PhD degree in virology from Glasgow University and appointed as Dean Assistant for scientific research in Dental College, then appointed as Head Department of Dental Basic Science and Director of Diagnostic lab in the Dental hospital, Mosul University. He has published more that 50 papers and supervised MSc and PhD students in the field of virology and oral microbiology. Prof. Taha is a member of Editorial Board of many journals in virology and Dental sciences. Prof. Taha has published many books in the field of Oral Microbiology and Virology.